NUZ.AX · NEURIZON THERAPEUTICS LIMITED
Australia · RS rating 49 · As of 2026-11-03
| Price | 0.06 AUD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 22 / 79 / 33 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 26 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +45.8% |
| Market cap (USD) | $47.8M |